C8 dihydro Ceramide (d18:0/8:0) – 1 mg

Brand:
Cayman
CAS:
145774-33-0
Storage:
-20
UN-No:
Non-Hazardous - /

C8 dihydro Ceramide is a sphingolipid and an intermediate in the synthesis of C8 ceramide (Item No. 62540).{36404} It is synthesized by the acylation of sphinganine by ceramide synthase, a process that can be inhibited by some fungal mycotoxins, such as fumonisin B1 (Item No. 62580).{5545} C8 dihydro Ceramide can be converted to C8 ceramide via the introduction of a 4,5-trans double bond by dihydroceramide desaturase.{36404} C8 dihydro ceramide is metabolically inactive and has been used as a negative control for the biological activity of C8 ceramide.{36405} [Matreya, LLC. Catalog No. 1854]  

 

Available on backorder

SKU: 24358 - 1 mg Category:

Description

A sphingolipid; an intermediate in the synthesis of C8 ceramide; synthesized by the acylation of sphinganine by ceramide synthase; can be converted to C8 ceramide; metabolically inactive and has been used as a negative control for the biological activity of C8 ceramide


Formal name: N-[(1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadecyl]-octanamide

Synonyms:  Cer(d18:0/8:0)|Ceramide (d18:0/8:0)|N-octanoyl-D-erythro-Dihydrosphingosine

Molecular weight: 427.7

CAS: 145774-33-0

Purity: ≥98%

Formulation: A solid


Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Lipid Biochemistry|Sphingolipids